Editorial: Pharmacovigilance and Drug Repositioning Research Using Pharmacoepidemiology
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Noguchi Y, Tachi T, Teramachi H
. Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source. Brief Bioinform. 2021; 22(6).
DOI: 10.1093/bib/bbab347.
View
2.
Fusaroli M, Isgro V, Cutroneo P, Ferrajolo C, Cirillo V, Del Bufalo F
. Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database. Drug Saf. 2022; 45(8):891-908.
PMC: 9360149.
DOI: 10.1007/s40264-022-01194-z.
View
3.
Kinoshita S, Hosomi K, Yokoyama S, Takada M
. Inverse Association between Metformin and Amiodarone-Associated Extracardiac Adverse Events. Int J Med Sci. 2020; 17(3):302-309.
PMC: 7053347.
DOI: 10.7150/ijms.39342.
View
4.
Lin L, Warren-Gash C, Smeeth L, Chen P
. Data resource profile: the National Health Insurance Research Database (NHIRD). Epidemiol Health. 2019; 40:e2018062.
PMC: 6367203.
DOI: 10.4178/epih.e2018062.
View
5.
Xia S, Gong H, Zhao Y, Guo L, Wang Y, Ma R
. Tumor Lysis Syndrome Associated with Monoclonal Antibodies in Patients with Multiple Myeloma: A Pharmacovigilance Study Based on the FAERS Database. Clin Pharmacol Ther. 2023; 114(1):211-219.
DOI: 10.1002/cpt.2920.
View